Skip to content

EJHP Highlights: Narrow therapeutic index drug formulations in transplantation

The latest edition of the European Journal of Hospital Pharmacy (EJHP) includes an article on the 2012 EAHP Congress Satellite Symposium on the subject of narrow therapeutic index drug (NTID) formulations in transplantation.

The article explores the debate about regarding generic drug substitution in solid organ transplant recipients and the concerns about potential adverse consequences from uncontrolled switching between the different narrow therapeutic index drug (NTID) formulations now available to the physician and pharmacist.
The symposium included perspectives from a transplant organ patient and heard from Professor Atholl Johnston (Professor of Clinical Pharmacology, Barts and The London School of Medicine and Dentistry, UK) on the issues around the generic drug approval process and bioequivalence.

Professor Teun van Gelder (Erasmus University Medical Center, The Netherlands) discussed the recently published European Society for Organ Transplantation (ESOT) recommendations on generic substitution of immunosuppressive drugs.
 

Full article available here

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.